Acumen Pharmaceuticals Valuation
| ABOS Stock | USD 2.37 0.06 2.60% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Acumen Pharmaceuticals shows a prevailing Real Value of $5.75 per share. The current price of the firm is $2.37. Our model approximates the value of Acumen Pharmaceuticals from analyzing the firm fundamentals such as Shares Owned By Insiders of 11.23 %, current valuation of (29.49 M), and Return On Equity of -0.33 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Acumen Pharmaceuticals' valuation include:
Price Book 0.6556 | Enterprise Value -29.5 M | Enterprise Value Ebitda (0.60) | Price Sales 538.7842 | Enterprise Value Revenue 89.674 |
Undervalued
Today
Please note that Acumen Pharmaceuticals' price fluctuation is relatively risky at this time. Calculation of the real value of Acumen Pharmaceuticals is based on 3 months time horizon. Increasing Acumen Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Acumen stock is determined by what a typical buyer is willing to pay for full or partial control of Acumen Pharmaceuticals. Since Acumen Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Acumen Stock. However, Acumen Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.37 | Real 5.75 | Target 16.0 | Hype 2.35 | Naive 1.98 |
The intrinsic value of Acumen Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Acumen Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Acumen Pharmaceuticals helps investors to forecast how Acumen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Acumen Pharmaceuticals more accurately as focusing exclusively on Acumen Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Acumen Pharmaceuticals' intrinsic value based on its ongoing forecasts of Acumen Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Acumen Pharmaceuticals' closest peers.
Acumen Pharmaceuticals Cash |
|
Acumen Valuation Trend
Acumen Pharmaceuticals' real value is important for investors to make better decisions and a more accurate overall view of Acumen Pharmaceuticals' financial worth over time. Using both Acumen Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Acumen Pharmaceuticals Total Value Analysis
Acumen Pharmaceuticals is presently estimated to have valuation of (29.49 M) with market capitalization of 142.39 M, debt of 28.49 M, and cash on hands of 189.91 M. The negative valuation of Acumen Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Acumen Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(29.49 M) | 142.39 M | 28.49 M | 189.91 M |
Acumen Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Acumen is to check how much profit was generated for every dollar of assets it reports. Acumen Pharmaceuticals shows a negative utilization of assets of -0.21 percent, losing $0.002099 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Acumen Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Acumen Pharmaceuticals Ownership Allocation
Acumen Pharmaceuticals holds a total of 60.08 Million outstanding shares. The majority of Acumen Pharmaceuticals outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Acumen Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Acumen Pharmaceuticals. Please pay attention to any change in the institutional holdings of Acumen Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Acumen Pharmaceuticals Profitability Analysis
Net Loss for the year was (52.37 M) with loss before overhead, payroll, taxes, and interest of (32.36 M).About Acumen Pharmaceuticals Valuation
The stock valuation mechanism determines Acumen Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Acumen Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acumen Pharmaceuticals. We calculate exposure to Acumen Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Acumen Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -42.3 M | -40.2 M | |
| Pretax Profit Margin | (5.87) | (6.16) | |
| Operating Profit Margin | (6.34) | (6.65) | |
| Net Loss | (5.87) | (6.16) | |
| Gross Profit Margin | 1.14 | 1.09 |
Acumen Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Acumen Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 48.6 M |
Acumen Pharmaceuticals Current Valuation Indicators
Acumen Pharmaceuticals' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Acumen Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Acumen Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Acumen Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Acumen Pharmaceuticals' worth.Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.